Announcements Trials
Browse Landscape

Status

Enrolling by invitation 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Lymphoma, Non-Hodgkin 3Lymphoma, B-Cell 2Lymphoma 2Triple Negative Breast Neoplasms 1Neuroblastoma 1Multiple Myeloma 1Lymphoma, T-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Prolymphocytic, B-Cell 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, B-Cell 1Leukemia 1Hodgkin Disease 1Hematologic Diseases 1Ganglioneuroblastoma 1Burkitt Lymphoma 1

Interventions

Rituximab 18Cyclophosphamide 17Prednisone 12Doxorubicin 12Vincristine 9Lenalidomide 7ibrutinib 6obinutuzumab 5glofitamab 5Magnetic Resonance Spectroscopy 5polatuzumab vedotin 4fludarabine 4Prednisolone 4Oxaliplatin 4Gemcitabine 4Etoposide 4venetoclax 3pembrolizumab 3fludarabine phosphate 3Whole-Body Irradiation 3Specimen Handling 3R-CHOP protocol 3Cyclosporine 3Biopsy 3zanubrutinib 2prednylidene 2deltacortene 2acalabrutinib 2Mycophenolic Acid 2Ifosfamide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Large B-Cell, Diffuse × Leukapheresis × 30 days × Clear all
NCT03226704 2026-05-20

Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing

National Institutes of Health Clinical Center (CC)

Enrolling by invitation
120 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡